$NVAX Recent News Novavax Inc. up 16% in premarket 6:52

New Post Public Reply Private Reply Replies (0) Message Board

Dec 26, 2013 at 6:11 PM

$NVAX Recent News

Novavax Inc. up 16% in premarket 6:52 a.m. Oct. 25, 2012 - Steve Gelsi
Novavax gains 11% on flu vaccine update 11:29 a.m. July 25, 2012 - Val Brickates Kennedy
Tuesday’s biggest gainers and decliners 6:42 p.m. March 1, 2011 - Kate Gibson
Novavax grabs drug-stock spotlight 12:49 p.m. March 1, 2011 - Val Brickates Kennedy
Novavax shares rally on government contract 10:03 a.m. March 1, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 3:38 p.m. July 27, 2010 - MarketWatch
Baxter, Affymetrix lead drug stocks lower 1:05 p.m. April 22, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 3:56 p.m. March 24, 2010 - MarketWatch
Poniard, Genzyme lead drug stocks south 10:10 a.m. March 24, 2010 - Val Brickates Kennedy
Drug stocks turn higher; Shire, XenoPort gain 12:59 p.m. Feb. 19, 2010 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 5:16 p.m. Feb. 8, 2010 - MarketWatch
Drug stocks turn higher; Cell Therapeutics tumbles 1:14 p.m. Feb. 8, 2010 - Val Brickates Kennedy
Novavax shares down 9% 9:37 a.m. Feb. 8, 2010 - Nick Godt
Novavax, Rovi end flu-vaccine-development plan 2:27 a.m. Feb. 8, 2010 - Robert Daniel
Novavax raises $21 million in stock offering 9:10 a.m. Dec. 9, 2009 - Val Brickates Kennedy
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Drug stocks split; Theravance slides on setback 1:22 p.m. Nov. 30, 2009 - Val Brickates Kennedy
Novavax sees Phase III vaccine testing in 2010 9:32 a.m. Nov. 30, 2009 - Val Brickates Kennedy
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch

Piper Jaffray Top Stocks to Buy for 2014 7:45 a.m. Dec. 18, 2013 - 247WallSt.com
Perilous Reversal Watch: Novavax (NVAX) 9:50 a.m. Dec. 17, 2013 - TheStreet.com
Mid-Afternoon Market Update: Markets Rise as Twitter Pulls Back 3:07 p.m. Dec. 16, 2013 - benzinga.com
Novavax Share Price Reaches New All-Time High 2:19 p.m. Dec. 16, 2013 - benzinga.com
Novavax jumps, Wedbush sees big upside 11:41 a.m. Dec. 16, 2013 - Seeking Alpha
Five Big Analyst Stock Picks for 2014 7:18 a.m. Dec. 14, 2013 - 247WallSt.com
Can Novavax, Inc. (NVAX) Continue to Rise? - Tale of the Tape 6:24 a.m. Dec. 12, 2013 - Zacks.com
Sell Organovo, Buy Novavax 3:09 a.m. Dec. 11, 2013 - Seeking Alpha
Novavax's CEO Presents at Piper Jaffray HC 2013 Conference (Transcript) 5:30 p.m. Dec. 3, 2013 - Seeking Alpha
New Top Stocks to Buy Under $10 with Big Upside 7:16 a.m. Nov. 18, 2013 - 247WallSt.com
Breakthrough In Virus Vaccination Can Instigate A Super Run Of Novavax 12:41 p.m. Nov. 17, 2013 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:11 a.m. Nov. 14, 2013 - benzinga.com
Novavax Shares Edge Higher as the New England Journal of Medicine Has Published Data on Co.'s Bird Flu Vaccine 4:27 p.m. Nov. 13, 2013 - benzinga.com
Novavax Management Discusses Q3 2013 Results - Earnings Call Transcript 7:20 p.m. Nov. 7, 2013 - Seeking Alpha
Buy Novavax On Vaccine Market Growth 1:31 p.m. Oct. 30, 2013 - Seeking Alpha
Wall Street Analysts’ Top Stocks to Buy Trading Under $10 6:36 a.m. Sept. 30, 2013 - 247WallSt.com
John McCamant Scans Under The Radar For Promising Biotechs 8:11 a.m. Sept. 27, 2013 - Seeking Alpha
Novavax: A Vaccine Company On The Rise 1:31 p.m. Sept. 25, 2013 - Seeking Alpha
Novavax: Why Investors Are Excited Now 11:22 a.m. Sept. 25, 2013 - Seeking Alpha
Novavax's CEO Hosts Analyst and Investor Update Conference (Transcript) 3:10 p.m. Sept. 24, 2013 - Seeking Alpha

Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Companies Report Corporate Growth and Positive Clinical Data - Research Report on Humana, Molina Healthcare, Novavax, Kindred Healthcare, and Repligen 8:00 a.m. Nov. 27, 2013 - PR Newswire
Novavax to Present at the 25th Annual Piper Jaffray Healthcare Conference 4:05 p.m. Nov. 26, 2013 - GlobeNewswire
Financial Reports, Partnerships, Settlement Agreements, and Strategic Acquisitions - Research Report on Mallinckrodt, WellCare, Mindray, Oxygen Biotherapeutics, and Novavax 8:00 a.m. Nov. 19, 2013 - PR Newswire
New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu 5:01 p.m. Nov. 13, 2013 - GlobeNewswire
Novavax Reports Third-Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - GlobeNewswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:29 a.m. Nov. 7, 2013 - ACCESSWIRE
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 12:30 p.m. Nov. 1, 2013 - PR Newswire
Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013 3:58 p.m. Oct. 30, 2013 - GlobeNewswire
Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc. 2:40 p.m. Oct. 10, 2013 - PR Newswire
Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray 7:00 a.m. Oct. 9, 2013 - PR Newswire
Novavax Initiates Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate 3:36 p.m. Oct. 7, 2013 - GlobeNewswire
Novavax Completes $100 Million Public Offering of Common Stock 10:29 a.m. Sept. 27, 2013 - GlobeNewswire
Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst 7:00 a.m. Sept. 27, 2013 - PR Newswire
Novavax Prices Public Offering of Common Stock 7:07 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA 7:00 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Host an Analyst and Investor Update Call With Webcast 5:25 p.m. Sept. 17, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...